Mirae Asset Global Investments
RAPT

Mirae Asset Global Investments’s RAPT Therapeutics RAPT Stock Holding History

Mirae Asset Global Investments’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,347
Closed -$45.6K – 1707
2025
Q4 		$45.6K Buy
+1,347
New +$41.8K ﹤0.01% 1411
2024
Q4 		– Sell
-158
Closed -$2.47K – 1655
2024
Q3 		$2.47K Buy
158
+28
+22% +$566 ﹤0.01% 1535
2024
Q2 		$3.01K Sell
130
-1,452
-92% -$67.1K ﹤0.01% 1501
2024
Q1 		$217K Sell
1,582
-994
-39% -$138K ﹤0.01% 2231
2023
Q4 		$512K Buy
2,576
+8
+0.3% +$990 ﹤0.01% 1958
2023
Q3 		$341K Sell
2,568
-152
-6% -$24.8K ﹤0.01% 2075
2023
Q2 		$408K Buy
2,720
+634
+30% +$98.8K ﹤0.01% 2033
2023
Q1 		$306K Buy
2,086
+605
+41% +$122K ﹤0.01% 2157
2022
Q4 		$235K Buy
1,481
+15
+1% +$2.4K ﹤0.01% 2250
2022
Q3 		$282K Buy
+1,466
New +$277K ﹤0.01% 2194

Mirae Asset Global Investments's RAPT Position: Q1 2026 in Review

Mirae Asset Global Investments sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 1,347 shares — an estimated $45.6K sold.

Mirae Asset Global Investments first reported a position in RAPT in Q3 2022 and held it in 10 quarters. The position peaked at $512K in Q4 2023. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

  • Mirae Asset Global Investments reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Mirae Asset Global Investments sold 1,347 RAPT Therapeutics shares in Q1 2026, an estimated $45.6K.
  • Mirae Asset Global Investments first reported a position in RAPT Therapeutics in Q3 2022 and held it in 10 quarters.
  • Mirae Asset Global Investments's RAPT Therapeutics position peaked at $512K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.